Marketing-authorisation holder · United States
Regcon Holdings
6 medicines in 1 country, as authorisation holder.
Medicines
Every medicine in the registers under its name, current ones first.
6 medicines
| Medicine | Substance | Country | Status | Authorised |
|---|---|---|---|---|
| BRIMONIDINE TARTRATE AND TIMOLOL MALEATE0.2%; 0.5% base · Solution/drops | Brimonidine, Timolol | United States | Marketed | 2022 |
| CETIRIZINE HYDROCHLORIDE10mg · Tablet | Cetirizine | United States | Marketed | 2024 |
| DORZOLAMIDE HYDROCHLORIDE AND TIMOLOL MALEATE2% base; 0.5% base · Solution/drops | Dorzolamide, Timolol | United States | Marketed | 2008 |
| LOFEXIDINE HYDROCHLORIDE0.18mg base · Tablet | Lofexidine | United States | Marketed | 2024 |
| OXYBUTYNIN CHLORIDE2.5mg | 5mg · Tablet | Oxybutynin | United States | Marketed | 1988 |
| SUCCINYLCHOLINE CHLORIDE100mg/vial | 20mg/ml · Injectable | Suxamethonium | United States | Marketed | 1972 |
Countries
Where it holds or makes medicines, with how many are current.
| Country | Medicines | Current | Past |
|---|